Skip to main content

Articles

Page 2 of 16

  1. This study aimed to assess the outcomes of thrombectomy with/without iliac vein stenting for young and transiently provoked DVT patients with iliac vein stenosis.

    Authors: Hongji Pu, Jumin Song, Zhijun He, Fuyin Wang, Jiateng Hu, Sheng Huang, Minyi Yin, Weimin Li, Xiaobing Liu, Xinwu Lu and Guang Liu
    Citation: Thrombosis Journal 2023 21:96
  2. Venous thromboembolism(VTE) is a leading cause of death in patients with lung cancer. Furthermore, hospitalization of patients with advanced lung cancer for VTE treatment represents a major economic burden on ...

    Authors: Wenjuan Di, Haotian Xu, Chunhua Ling and Ting Xue
    Citation: Thrombosis Journal 2023 21:95
  3. Tranexamic acid (TXA) is a widely used antifibrinolytic agent that has been used since the 1960’s to reduce blood loss in various conditions. TXA is a lysine analogue that competes for the lysine binding sites...

    Authors: Tammy Lam, Robert L. Medcalf, Geoffrey C. Cloud, Paul S. Myles and Charithani B. Keragala
    Citation: Thrombosis Journal 2023 21:94
  4. The prevalence of anti-platelet factor 4 (PF4)/polyanionic antibodies occurring after vaccination with ChAdOx1 nCoV-19 is low. Most of these antibodies are not associated with vaccine-induced thrombotic thromb...

    Authors: Kochawan Boonyawat, Tichayapa Phojanasenee, Phichchapha Noikongdee, Pornnapa Police, Pichika Chantrathammachart, Pimjai Niparuck, Teeraya Puavilai, Angsana Phuphuakrat and Pantep Angchaisuksiri
    Citation: Thrombosis Journal 2023 21:92
  5. Upon cellular injury, damage-associated molecular patterns (DAMPs) are released into the extracellular space and evoke proinflammatory and prothrombotic responses in animal models of sterile inflammation. Howe...

    Authors: Kenshin Shimono, Takashi Ito, Chinatsu Kamikokuryo, Shuhei Niiyama, Shingo Yamada, Hirokazu Onishi, Hideaki Yoshihara, Ikuro Maruyama and Yasuyuki Kakihana
    Citation: Thrombosis Journal 2023 21:91
  6. An established treatment strategy for asymptomatic pulmonary embolism (PE) or deep vein thrombosis (DVT) remains uncertain in Japan; therefore, in this study, we clarify the characteristics and outcomes of sym...

    Authors: Shohei Migita, Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda, Takeshi Yamashita, Takanori Ikeda, Makoto Mo, Tsutomu Yamazaki and Atsushi Hirayama
    Citation: Thrombosis Journal 2023 21:88
  7. Takayasu’s arteritis (TAK) is a rare chronic granulomatous arteritis that mainly affects the aorta and its major branches. Coronary artery (CA) involvement can be observed in 10–25% of TAK patients. We report ...

    Authors: Shichu Liang, Jinming Yang, Min Ma, Minggang Zhou, Zhiyue Liu, He Huang and Yong He
    Citation: Thrombosis Journal 2023 21:87
  8. Despite the risks of venous thromboembolism (VTE) in surgical patients are well defined, primary thromboprophylaxis (TP) can be neglected. The aim of this study was to evaluate the risk of VTE and appropriaten...

    Authors: Zeynep Karaburç Kiracı, Nadir Yalçın, Ömer Cennet, Kutay Demirkan and Kaya Yorgancı
    Citation: Thrombosis Journal 2023 21:86
  9. Lavender oil (LO) possesses anti-inflammatory, antioxidant, antifungal, antibacterial, sedative, cardio-protective, and antinociceptive properties. Thrombosis and inflammation are interplayed processes that in...

    Authors: Valeriu Mihai But, Adriana Elena Bulboacă, Vasile Rus, Tamás Ilyés, Mădălina Luciana Gherman and Sorana D. Bolboacă
    Citation: Thrombosis Journal 2023 21:85
  10. We compared the prognostic value of the Japanese Society on Thrombosis and Hemostasis (JSTH) disseminated intravascular coagulation (DIC) diagnostic criteria with that of the International Society on Thrombosi...

    Authors: Hirotaka Mori, Kayo Harada-Shirado, Noriaki Kawano, Mineji Hayakawa, Yoshinobu Seki, Toshimasa Uchiyama, Kazuma Yamakawa, Hiroyasu Ishikura, Yuhei Irie, Kenji Nishio, Noritaka Yada, Kohji Okamoto and Takayuki Ikezoe
    Citation: Thrombosis Journal 2023 21:84
  11. Stroke prevention with oral anticoagulant (OAC) therapy, including non-vitamin K antagonist oral anticoagulants (NOACs), is recommended in patients with atrial fibrillation (AF). This analysis describes the an...

    Authors: Xiaoxia Liu, Guoze Feng, Sabrina Vogel Marler, Menno V Huisman, Gregory Y. H. Lip and Changsheng Ma
    Citation: Thrombosis Journal 2023 21:83
  12. Venous thromboembolism (VTE) is a common thrombotic vascular disease that has a significant impact on people’s well-being and quality of life. A plethora of clinical studies explore the relationship between in...

    Authors: Jiayue Ding, Xuanye Yue, Xiaobing Tian, Zhangyuan Liao, Ran Meng and Ming Zou
    Citation: Thrombosis Journal 2023 21:82
  13. Central retinal artery occlusion (CRAO) is a common cause of blindness and visual morbidity. In the majority of cases, it is related to thrombotic embolism. Nevertheless, the role of inherited or acquired thro...

    Authors: Radosław Dziedzic, Lech Zaręba, Teresa Iwaniec, Agnieszka Kubicka-Trząska, Bożena Romanowska-Dixon, Stanisława Bazan-Socha and Jerzy Dropiński
    Citation: Thrombosis Journal 2023 21:81
  14. Because severe acute respiratory syndrome coronarivus 2 (SARS-CoV-2) leads to severe conditions and thrombus formation, evaluation of the coagulation markers is important in determining the prognosis and pheno...

    Authors: Emily Corneo, Rafael Garbelotto, Gabriele Prestes, Carolina Saibro Girardi, Lucas Santos, Jose Claudio Fonseca Moreira, Daniel Pens Gelain, Glauco A. Westphal, Emil Kupek, Roger Walz, Cristiane Ritter and Felipe Dal-Pizzol
    Citation: Thrombosis Journal 2023 21:80
  15. Antiplatelet drugs, such as Aspirin and Clopidogrel (Plavix) are effective in the primary prevention of thromboembolic events. They are commonly used to reduce the risk of recurrence of thromboembolism. The bo...

    Authors: Mohammad Parsa-kondelaji and Hassan Mansouritorghabeh
    Citation: Thrombosis Journal 2023 21:79
  16. Cortical vein thrombosis (CVT) is a rare form of cerebral venous sinus thrombosis (CVST) in adolescent patients that has received little attention. We aimed to analyze the clinical and radiological features of...

    Authors: Lu Liu, Chenxia Zhou, Huimin Jiang, Huimin Wei, Yifan Zhou, Yan Wu, Kaiyuan Zhang, Chuanhui Li, Jiangang Duan, Ran Meng, Chen Zhou and Xunming Ji
    Citation: Thrombosis Journal 2023 21:78
  17. Intracoronary (IC) administration of glycoprotein IIb/IIIa inhibitors (GPIs) has been studied as an adjunctive therapy to improve outcomes in patients with ST-segment elevation myocardial infarction (STEMI) un...

    Authors: JongSung Hahn, Jinyoung Jeon, Min Jung Geum, Hyun Woo Lee, Jaekyu Shin, Woo-Young Chung, Yun Mi Yu and Young-Mi Ah
    Citation: Thrombosis Journal 2023 21:76
  18. Contemporary data regarding the clinical characteristics and prognosis of left ventricular thrombus (LVT) in older adults (aged ≥ 65 years old) are lacking. In this study, we characterized elderly patients wit...

    Authors: Qian Zhang, Zhongfan Zhang, Haikuo Zheng, Chengbing Wang, Miao Yu, Daoyuan Si and Wenqi Zhang
    Citation: Thrombosis Journal 2023 21:75
  19. With its low morbidity and high mortality rates, thrombotic thrombocytopenic purpura (TTP) has imposed a critical physical and economic burden on both society and individuals. Thrombocytopenia commonly occurs ...

    Authors: Yingwei Ou, Yifan Xu, Zhaowang Tan, Lingxiao Pang, Shengqin Li, Qian Li, Wenwei Cai, Yong Nan and Jianfeng Tu
    Citation: Thrombosis Journal 2023 21:74
  20. High venous thromboembolism (VTE) rates have been described in critically ill patients with COVID-19. We hypothesized that specific clinical characteristics may help differentiate hypoxic COVID-19 patients wit...

    Authors: Jeeyune Bahk, Abdul Rehman, Kam Sing Ho, Bharat Narasimhan, Hafiza Noor Ul Ain Baloch, Jiafang Zhang, Rowena Yip, Robert Lookstein and David J Steiger
    Citation: Thrombosis Journal 2023 21:73

    The Correction to this article has been published in Thrombosis Journal 2023 21:89

  21. An accumulating body of evidence has shown that gut microbiota is involved in regulating inflammation; however, it remains undetermined if and how gut microbiota plays an important role in modulating deep veno...

    Authors: Cheng Liu, Ying Zhou, Huihui Gao, Zeping Zhang, Yu Zhou, Zifeng Xu, Chenhong Zhang, Zhen Xu, Huajun Zheng and Yan-Qing Ma
    Citation: Thrombosis Journal 2023 21:71
  22. In patients with hemophilia (PwH), bleeding often occurs in joints and muscles, and early detection of hemorrhage is important to prevent the onset and progression of mobility impairment. Complex-Image analysi...

    Authors: Ryohei Kawasaki, Asuka Sakata, Chihiro Hosoda, Suguru Harada, Tetsuhiro Soeda, Yukiko Nishida, Naoki Matsumoto, Kohei Tatsumi, Keiji Nogami, Yasushi Yoshimura and Midori Shima
    Citation: Thrombosis Journal 2023 21:70
  23. Immune thrombocytopenia (ITP), which is a well-known hemorrhagic disorder characterized by low platelet counts, has been shown to be associated with the risk of thrombosis. Thrombopoietic agents (TAs) are exte...

    Authors: Yu Dong, Zhinan Xia, Jie Zhou, Yutao Hu, Ming Yue, Yuyong Wang and Mengjiao Hu
    Citation: Thrombosis Journal 2023 21:69
  24. Right heart thrombus in transit or “free-floating right heart thrombus” is defined as thrombus(i) arising from the deep veins that embolises to the right atrium or right ventricle before reaching the pulmonary...

    Authors: Rezwan N Hussain, Amit K J Mandal, Nick Li, Jihène El Kafsi, Anastasis Sioftanos and Constantinos G Missouris
    Citation: Thrombosis Journal 2023 21:68
  25. Neutrophil extracellular traps (NETs) as special release products of neutrophils have received extensive attention. They are composed of decondensed chromatin and coated with nucleoproteins, including histones...

    Authors: Weiwei Li, Zixiang Wang, Chen’guang Su, Zheng Liao, Yinxuan Pei, Jianli Wang, Zixin Li, Shijie Fu and Jinlong Liu
    Citation: Thrombosis Journal 2023 21:67
  26. Venous thromboembolism (VTE) is a leading cause of morbidity and mortality during pregnancy and the puerperium. The vast majority of VTE occurs after childbirth. China has not yet established standard risk ass...

    Authors: Hua Li, Sheng Wan, Jindan Pei, Lu Zhang, Jing Peng and Ronghua Che
    Citation: Thrombosis Journal 2023 21:66
  27. Bleeding and thrombotic complications are the leading causes of death in acute leukemia patients. The Conventional International Society of Thrombosis and Haemostasis Disseminated Intravascular Coagulation (IS...

    Authors: Weerapat Owattanapanich, Tarinee Rungjirajittranon, Apichaya Jantataeme, Smith Kungwankiattichai and Theera Ruchutrakool
    Citation: Thrombosis Journal 2023 21:65
  28. The incidence of incidental pulmonary embolism (IPE) has greatly increased, but its clinical characteristics and outcomes are still controversial. This study aimed to compare the clinical characteristics and o...

    Authors: Yanfei Wang, Zhongfen Liu, Qiuyu Li, Lina Xia, Yunyi Wang, Danfeng Jiang, Xiaoyan Chen, Yanqun Zheng, Wei Liu, Dan Wang and Dong Xue
    Citation: Thrombosis Journal 2023 21:64
  29. The Khorana score (KS) has not been well studied in East Asian cancer patients, who have different genetic backgrounds for inherited thrombophilia, body metabolism, and cancer epidemiology.

    Authors: Hyerim Ha, Yeh-Hee Ko, Kwangsoo Kim, Junshik Hong, Gyeong-Won Lee, Seong Hyun Jeong, Soo-Mee Bang and Sung-Soo Yoon
    Citation: Thrombosis Journal 2023 21:63
  30. Neonatal portal vein thrombosis (PVT) is currently more commonly encountered as a result of advances in diagnostic tools and increase in invasive interventions.

    Authors: Huseyin Avni Solgun, Ezgi Paslı Uysalol, Cengiz Bayram, Özlem Terzi, Merih Çetinkaya, Şeyma Memur and Ali Aycicek
    Citation: Thrombosis Journal 2023 21:62
  31. Cancer-associated thrombosis is a frequent complication of cancer; however, little evidence is available regarding the association between cancer history and coronary artery stent thrombosis (ST). We aimed to ...

    Authors: Tomoyo Hamana, Hiromasa Otake, Shoichi Kuramitsu, Tomohiro Shinozaki, Masanobu Ohya, Kazunori Horie, Hiroyoshi Kawamoto, Futoshi Yamanaka, Masahiro Natsuaki, Hiroki Shiomi, Gaku Nakazawa, Kenji Ando, Kazushige Kadota, Shigeru Saito and Takeshi Kimura
    Citation: Thrombosis Journal 2023 21:60
  32. Venous thromboembolism (VTE) prophylaxis is effective in reducing VTE events, however, its impact on mortality is unclear. We examined the association between omission of VTE prophylaxis within the first 24 h ...

    Authors: Berhe W. Sahle, David Pilcher, Karlheinz Peter, James D. McFadyen, Edward Litton and Tracey Bucknall
    Citation: Thrombosis Journal 2023 21:59
  33. The assessment of hemostasis is necessary to make suitable decisions on the management of patients with thrombotic disorders. In some clinical situations, for example, during thrombophilia screening, the prese...

    Authors: Aleksandra Frackiewicz, Bartlomiej Kalaska, Joanna Miklosz and Andrzej Mogielnicki
    Citation: Thrombosis Journal 2023 21:58
  34. Gynecological cancer is one of the highest risk factors for cancer-associated thrombosis (CAT). Although low-molecular-weight heparin (LMWH) is recommended as an anticoagulant for treating CAT, recent studies ...

    Authors: Tadashi Oride, Kenjiro Sawada, Aasa Shimizu, Yasuto Kinose, Tsuyoshi Takiuchi, Michiko Kodama, Kae Hashimoto, Eiji Kobayashi, Eiji Nakatani and Tadashi Kimura
    Citation: Thrombosis Journal 2023 21:57
  35. Postoperative lung cancer patients belong to the high-risk group for venous thromboembolism (VTE). The standardized preventive measures for perioperative VTE in lung cancer are not perfect, especially for the ...

    Authors: Jingyao Li, Aihong Huang, Zhaojie Han, Yi Zhou, Meng Tang, Wei Wu, Shixin Zhang, Kelong Liao, Yihui Xie, Qiao Chen, Xinliang Zou, Shuai Liu, Shuaixiang Gao, Junlong Ren, Qingyuan Xu, Xi Liu…
    Citation: Thrombosis Journal 2023 21:56
  36. Deep vein thrombosis (DVT) is a common complication in cancer. Although thromboprophylaxis in cancer patients is recommended by the guidelines, clinicians’ use of thromboprophylaxis remains limited due to cost...

    Authors: Budi Setiawan, Widi Budianto, Tri Wahyu Sukarnowati, Daniel Rizky, Eko Adhi Pangarsa, Damai Santosa, Aru Wisaksono Sudoyo, Tri Indah Winarni, Ignatius Riwanto, Rahajuningsih Dharma Setiabudy and Catharina Suharti
    Citation: Thrombosis Journal 2023 21:54
  37. Pulmonary embolism (PE) is an important complication of Coronavirus disease 2019 (COVID-19). COVID-19 is associated with respiratory impairment and a pro-coagulative state, rendering PE more likely and difficu...

    Authors: Jakob Vielhauer, Christopher Benesch, Anna Pernpruner, Anna-Lena Johlke, Johannes Christian Hellmuth, Maximilian Muenchhoff, Clemens Scherer, Nicola Fink, Bastian Sabel, Christian Schulz, Julia Mayerle, Ujjwal Mukund Mahajan and Hans Christian Stubbe
    Citation: Thrombosis Journal 2023 21:51
  38. It remains unknown whether anticoagulation for persistent left ventricular (LV) thrombus should be continued indefinitely. Identifying patients with a high risk of thrombus unresolved may be helpful to determi...

    Authors: Qing Yang, Xin Quan, Chuangshi Wang, Litian Yu, Yanmin Yang, Jun Zhu and Yan Liang
    Citation: Thrombosis Journal 2023 21:50
  39. There is room for improvement of prevention of venous thromboembolism (VTE) after lower-leg cast application or knee arthroscopy. Information about the mechanism of clot formation in these patients may be usef...

    Authors: Carolina E. Touw, Banne Nemeth, Raymond A. van Adrichem, Astrid van Hylckama Vlieg, Rob G. H. H. Nelissen, Ton Lisman and Suzanne C. Cannegieter
    Citation: Thrombosis Journal 2023 21:49
  40. The first case of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) was reported in the letter-to-editor submission in the journal of Indian Journal of Hematology and Blood Transfusion which was published onl...

    Authors: Jyoti Kotwal and K. V. Vinu Balraam
    Citation: Thrombosis Journal 2023 21:47

    The original article was published in Thrombosis Journal 2022 20:11

    The Response to this article has been published in Thrombosis Journal 2023 21:48

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

    Members of APSTH are entitled to a 15% discount on the article processing charge.

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2022 Speed
    12 days submission to first editorial decision for all manuscripts (Median)
    121 days submission to accept (Median)

    2022 Usage 
    617,320 downloads
    3,882 Altmetric mentions